tiprankstipranks

David Scheinberg Insider Profile

4 Followers
David Scheinberg, Director at Progenics, holds 10.58K shares in SELLAS Life Sciences Group (Ticker: SLS), holds 56.19K shares in Progenics (Ticker: PGNX), holds 15.77K shares in ContraFect (Ticker: CFRXQ).
tipranks
David Scheinberg

David Scheinberg
Progenics (PGNX)
Director

Not Ranked
David Scheinberg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14K
98.30%
1.70%
A breakdown of David Scheinberg's holdings

Insider Roles

SELLAS Life Sciences Group
(SLS)
Director
ContraFect
(CFRXQ)
Director
Roles that David Scheinberg holds in companies

Most Profitable Insider Trade

Stock:
Progenics
(PGNX)
Rating:Informative Buy
Date:Jul 03, 2019 - Jul 03, 2020
Return:-30.30%
The most profitable trade made by David Scheinberg

David Scheinberg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PGNX
Progenics
Jul 03, 2019
Informative Buy
53.30K
$230.36K
SELLAS Life Sciences Group
Jan 25, 2024
Director
Uninformative Buy
$13.65K
ContraFect
Jul 28, 2014
Director
Uninformative Buy
$236.55
List of latest transactions for each holding click on a transaction to see David Scheinberg's performance on stock

David Scheinberg insider profile FAQ

What is the percentage of profitable transactions made by David Scheinberg?
The percentage of profitable transactions made by David Scheinberg is ―.
    What is the average return per transaction made by David Scheinberg?
    The average return per transaction made by David Scheinberg is ―.
      What stocks does David Scheinberg hold?
      David Scheinberg holds: PGNX, SLS, CFRXQ stocks.
        What was David Scheinberg’s latest transaction?
        David Scheinberg latest transaction was an Uninformative Buy of ―.
          What was David Scheinberg's most profitable transaction?
          David Scheinberg’s most profitable transaction was an Informative Buy of PGNX stock on July 3, 2019. The return on the trade was -30.30%.
            What is David Scheinberg's role in Progenics?
            David Scheinberg's role in Progenics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.